Advisor Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$48K Sell
1,183
-102
-8% -$3.81K ﹤0.01% 3443
2019
Q3
$44K Sell
1,285
-510
-28% -$16.8K ﹤0.01% 3483
2019
Q2
$56K Buy
1,795
+83
+5% +$2.47K ﹤0.01% 3287
2019
Q1
$51K Sell
1,712
-875
-34% -$25.1K ﹤0.01% 3376
2018
Q4
$80K Buy
2,587
+286
+12% +$10.4K ﹤0.01% 2831
2018
Q3
$87K Buy
2,301
+648
+39% +$24.5K ﹤0.01% 2860
2018
Q2
$64K Sell
1,653
-404
-20% -$13.6K ﹤0.01% 2888
2018
Q1
$69K Sell
2,057
-14,095
-87% -$541K ﹤0.01% 2843
2017
Q4
$717K Buy
16,152
+706
+5% +$32.2K 0.01% 1099
2017
Q3
$774K Buy
15,446
+13,161
+576% +$672K 0.01% 956
2017
Q2
$120K Buy
2,285
+570
+33% +$30.5K ﹤0.01% 2163
2017
Q1
$95K Buy
1,715
+51
+3% +$2.81K ﹤0.01% 2196
2016
Q4
$87K Sell
1,664
-284
-15% -$13.7K ﹤0.01% 2177
2016
Q3
$94K Sell
1,948
-1,384
-42% -$70K ﹤0.01% 2049
2016
Q2
$182K Buy
+3,332
New +$184K ﹤0.01% 1529

Other funds holding PBH

Advisor Group's PBH Position: Q4 2019 in Review

Advisor Group reduced its Prestige Consumer Healthcare (PBH) stake by 7.9% in Q4 2019, selling an estimated $3.81K and leaving 1,183 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #3443.

Advisor Group first reported a position in PBH in Q2 2016 and has held it in 15 quarters since. The position peaked at $774K in Q3 2017. 234 funds tracked by Wall St. Rank hold PBH as of Q4 2019.

  • Advisor Group held 1,183 shares of Prestige Consumer Healthcare worth $48K as of Q4 2019.
  • Advisor Group sold 102 Prestige Consumer Healthcare shares in Q4 2019, an estimated $3.81K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3443 holding.
  • Advisor Group first reported a position in Prestige Consumer Healthcare in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Prestige Consumer Healthcare position peaked at $774K in Q3 2017.
  • 234 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.